Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accel Entertainment | ACEL | Jun 14, 2024 | 9.94 | -1.78 |
Accelerate Diagnostics | AXDX | Jun 14, 2024 | 1.35 | +0.75 |
Accenture A | ACN | Jun 14, 2024 | 286.71 | +1.56 |
Acco Brands | ACCO | Jun 14, 2024 | 4.68 | -2.50 |
Accolade | ACCD | Jun 14, 2024 | 6.18 | -4.19 |
Accuray | ARAY | Jun 14, 2024 | 1.73 | -1.70 |
Ace Global Business Acquisition | ACBA | Jun 14, 2024 | 12.03 | 0.00 |
Ace Global Business Acquisition Unit | ACBAU | Jun 14, 2024 | 12.00 | 0.00 |
Acelyrin | SLRN | Jun 14, 2024 | 4.18 | -4.13 |
Achieve Life Sciences | ACHV | Jun 14, 2024 | 4.90 | -3.73 |
Achilles Therapeutics ADR | ACHL | Jun 14, 2024 | 0.90 | -0.55 |
ACI Worldwide | ACIW | Jun 14, 2024 | 35.79 | +0.90 |
Aclarion | ACON | Jun 14, 2024 | 0.30 | +2.64 |
Aclaris Therapeutics | ACRS | Jun 14, 2024 | 1.18 | -0.84 |
ACM Research A | ACMR | Jun 14, 2024 | 23.54 | -7.50 |
Acme United | ACU | Jun 14, 2024 | 33.70 | -2.88 |
ACNB | ACNB | Jun 14, 2024 | 31.07 | -1.55 |
ACRES Commercial Realty | ACR | Jun 14, 2024 | 12.87 | +0.47 |
ACRES Commercial Realty C Pref | ACR-C | Jun 14, 2024 | 24.83 | -0.24 |
ACRES Commercial Realty D Pref | ACR-D | Jun 14, 2024 | 21.65 | 0.00 |
Acrivon Therapeutics | ACRV | Jun 14, 2024 | 7.25 | -6.09 |
Actelis Networks | ASNS | Jun 14, 2024 | 1.35 | -5.59 |
Actinium Pharmaceuticals | ATNM | Jun 14, 2024 | 7.82 | -2.49 |
Active Bear ETF | HDGE | Jun 14, 2024 | 21.13 | +1.15 |
Active U.S. Real Estate Powershares | PSR | Jun 14, 2024 | 85.55 | +0.03 |
Acuity Brands | AYI | Jun 14, 2024 | 252.38 | -2.64 |
Acumen Pharmaceuticals | ABOS | Jun 14, 2024 | 2.64 | 0.00 |
Acurx Pharmaceuticals | ACXP | Jun 14, 2024 | 2.43 | -2.02 |
Acushnet | GOLF | Jun 14, 2024 | 63.81 | -0.76 |
ACV Auctions A | ACVA | Jun 14, 2024 | 17.69 | -3.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.